MedPath

Cardiac Resynchronization Therapy Delivery Guided Non-Invasive Electrical and Venous Anatomy Assessment

Not Applicable
Recruiting
Conditions
Chronic Heart Failure
Cardiac Resynchronization Therapy
Left Bundle-Branch Block
Registration Number
NCT05327062
Lead Sponsor
XSpline S.p.A.
Brief Summary

The objective of this prospective, multicenter controlled study is to assess the feasibility of a patient-tailored implantation by creating a cloud-based pre-procedural multimodality CRT-roadmap by integration of 3D images from 3D activation sequence from ECG, and coronary venous anatomy from cardiac computed tomography. This CRT-roadmap will be used to guide LV lead placement to a coronary vein in an electrically late-activated region.

Study Hypothesis: At least 75% of patients undergoing a CRT implantation guided by non-invasive electrical and venous anatomy assessment (XSPLINE technology) will show a reduction of left ventricular end-systolic volume of 15% or more at 6-month evaluation.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
150
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Reduction of left ventricular end-systolic volume of at least 15% in 75% of CRT treated patients6 months follow-up

Increase in efficacy of CRT using XSpline technology assessed by reduction of left ventricular end-systolic volume of at least 15% at 6-month follow-up in 75% of CRT treated patients, based on routine echo-cardiographic measurements

Secondary Outcome Measures
NameTimeMethod
Total X-ray exposure time difference6 months follow-up

Evaluate the change in total X-ray exposure time by comparing with standard approach as found in literature, time in minutes

CRT procedural time difference6 months follow-up

Evaluate the change in CRT procedural time by comparing with standard approach as found in literature, time in minutes

Feasibility of systematic use of XSpline platform for CRT implantation6 months follow-up

Feasibility of systematic use of automatic cloud-based, AI-based XSpline technology through statistics on software performance (e.g. percentage of core tasks completed higher than defined thresholds)

Trial Locations

Locations (13)

Rush University Medical center

🇺🇸

Chicago, Illinois, United States

The University of Chicago Medicine

🇺🇸

Chicago, Illinois, United States

Massachusetts General Hospital

🇺🇸

Boston, Massachusetts, United States

Duke University Hospital

🇺🇸

Durham, North Carolina, United States

Ordensklinikum Linz Elisabethinen Hospital

🇦🇹

Linz, Austria

Semmelweis University

🇭🇺

Budapest, Hungary

General Hospital of Bolzano

🇮🇹

Bolzano, Italy

Fondazione IRCCS Policlinico San Matteo

🇮🇹

Pavia, Italy

University Tor Vergata

🇮🇹

Roma, Italy

Ospedale S. Maria del Carmine di Rovereto

🇮🇹

Rovereto, Italy

Scroll for more (3 remaining)
Rush University Medical center
🇺🇸Chicago, Illinois, United States
Parikshit S Sharma
Contact
parikshit_S_Sharma@rush.edu
Parikshit S Sharma, MD
Contact

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.